Desmoids are rare, benign fibromatous lesions, which can arise in patients with familial adenomatous polyposis (FAP), a disorder caused by germline adenomatous polyposis coli (APC) gene mutation. This study investigated the risk of desmoids in FAP, the relation between specific APC gene mutations and desmoid formation, and the clinical characteristics of FAP patients with desmoids. Eighty three of 825 FAP patients (10%) from 49 of 161 kindreds (30%) had desmoids. The absolute risk of desmoids in FAP patients was 2-56/1000 person years; comparative risk was 852 times the general population. APC gene mutations were similar in families with and without desmoids. The female/male ratio was 1*4 (p=NS). Previous abdominal surgery was noted in 68% of patients with abdominal desmoids (55% developed within five years postoperatively). Desmoid risk in FAP family members of a desmoid patient was 25% in first degree relatives v 8% in third degree relatives. Desmoids are a comparatively common complication of FAP associated with surgical trauma and familial aggregation. Desmoid development was not linked to specific APC gene mutations and was not found predominantly in women. Studies of chemopreventive therapy, given within five years after abdominal surgery, should be considered in FAP patients with a family history of desmoid disease. (Gut 1994; 35: 377-381) Desmoids are benign fibromatous lesions that arise most often in the abdominal wall and mesentery but also occasionally in the extremities and trunk. Desmoids occur rarely, constituting less than 0-1% of all tumours'2 with an incidence of 2-4 cases/million/year,23 and develop mainly in women. Patients with familial adenomatous polyposis (FAP) 
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was noted in 68% of patients with abdominal desmoids (55% developed within five years postoperatively). Desmoid risk in FAP family members of a desmoid patient was 25% in first degree relatives v 8% in third degree relatives. Desmoids are a comparatively common complication of FAP associated with surgical trauma and familial aggregation. Desmoid development was not linked to specific APC gene mutations and was not found predominantly in women. Studies of chemopreventive therapy, given within five years after abdominal surgery, should be considered in FAP patients with a family history of desmoid disease. (Gut 1994; 35: [377] [378] [379] [380] [381] Desmoids are benign fibromatous lesions that arise most often in the abdominal wall and mesentery but also occasionally in the extremities and trunk. Desmoids occur rarely, constituting less than 0-1% of all tumours'2 with an incidence of 2-4 cases/million/year,23 and develop mainly in women. Patients with familial adenomatous polyposis (FAP) The location and type of APC gene mutation in the families with a member who had desmoid disease were compared with families who had no desmoids (Fig 1) . In both desmoid and non-desmoid pedigrees, mutations occurred throughout the length of the APC gene, and the types of mutation (frameshift v point mutation) were sinilar. (Fig 2) . There was no difference by sex in mean age at diagnosis or age distribution of desmoids.
In 56 of 83 patients (68%), the diagnosis of desmoid disease occurred after the diagnosis of FAP (mean of 9 (9) years after the diagnosis of FAP); in 11 patients (13%), desmoids developed a mean of 10 (8) (Table  II) . When kindreds with more than one desmoid case were evaluated, the prevalence was similar (49/216; 23%). When the risk by degree of relation to a desmoid case was examined, however, first degree relatives of a desmoid patient were at greater risk of desmoids than more distant relations. As shown in Table III , the empiric risk to first degree relatives was 25%, which was more than twice that of second and third degree relatives. By contrast, the risk to second and third degree relatives approached the overall 10% risk of desmoids in FAP patients in general. As Figure 1 shows, the location and type of APC gene mutation did not differ among families with single or multiple members with desmoid disease.
Complications from desmoid were the cause of death in eight of 83 cohort patients (10%). By lifetable analysis, the survival rate from desmoids was 93% at five years and 79% at 20 Some investigators have identified surgical trauma as a precipitating factor for desmoid formation in FAP patients.3"2"6'7 Our findings support this concept, as 68% of our patients with an abdominal desmoid had had abdominal surgery. In smaller published series, the mean time from colectomy to desmoid formation was 2-3 years." 32 In our cohort, most patients developed desmoids by five years postoperatively, but the mean time to desmoid formation was nine years. The difference in these temporal findings probably relates to the much longer follow up in our patient population (almost 14 years v 4 years).
A similar mean age of prophylactic colectomy in FAP patients with and without abdominal desmoids in our cohort suggests that age at colectomy is not an important factor in desmoid formation. There was a slight suggestion, however, from our data that patients having prophylactic colectomy at a younger age developed desmoids sooner than patients who were older at colectomy. This finding needs further investigation because of the implications for timing of prophylactic colectomy.
Finally, the significance of family history of desmoids as a risk factor for the development of desmoids in other pedigree members has been unclear, as only a few families had been studied. Fifty nine per cent of our study patients from 15 families, however, had a family history of desmoids, and this frequency agrees with a previous review of published works'8 that reported 56%. In our pedigrees, the percentage of FAP patients affected with desmoids was as high as 86% (6/7) and 100% (2/2). Familial 
